Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q 2025Expect to ...
Tired of 'fixing the chatbot?' Let's build an AI system that thinks with you and turns your team's knowledge into measurable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback